echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Production Process of Trifluperidol

    The Production Process of Trifluperidol

    • Last Update: 2023-05-10
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Trifluoperidol is a synthetic compound that is used as a precursor in the production of certain pharmaceuticals and dyes.
    The production process of trifluoperidol involves several steps, which are outlined below.


    Step 1: Synthesis of 2,3-dimethyl-1,4-benzoxazepine
    The first step in the production of trifluoperidol is the synthesis of 2,3-dimethyl-1,4-benzoxazepine, which is synthesized by reaction of dimethyl-1,4-benzoxazepine with chloral hydrate in the presence of an acid catalyst.


    Step 2: Condensation of 2,3-dimethyl-1,4-benzoxazepine with acetic anhydride
    Next, 2,3-dimethyl-1,4-benzoxazepine is condensed with acetic anhydride in the presence of a strong acid catalyst to form 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(acetoxy)-propan-2-one.


    Step 3: Reduction of 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(acetoxy)-propan-2-one
    The next step is the reduction of 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(acetoxy)-propan-2-one using a reducing agent such as lithium aluminum hydride (LiAlH4) to form 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(hydroxy)-propan-2-one.


    Step 4: Bromination of 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(hydroxy)-propan-2-one
    The bromination of 1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-(hydroxy)-propan-2-one is carried out using a bromine source, such as N-bromosuccinimide (NBS), in the presence of a solvent such as chloroform.


    Step 5: Coupling of 4-bromo-1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-hydroxy-propan-2-one with tetracyclic guanidine
    The next step is the coupling of 4-bromo-1-(2,3-dimethyl-1,4-benzoxazepin-7-yl)-3-hydroxy-propan-2-one with tetracyclic guanidine to form 1,4-dimethyl-7-[4-(4-bromo-1,3-oxazepan-2-yl)-tetracyclo[4.
    4.
    0.
    12,5.
    17,10]hept-9-yl]-1,4-benzoxazepine.


    Step 6: Reduction of 1,4-dimethyl-7-[4-(4-bromo-1,3-oxazepan-2-yl)-tetracyclo[4.
    4.
    0.
    12,5.
    17,10]hept-9-yl]-1,4-benzoxazepine
    The last step is the reduction of 1,4-dimethyl-7-[4-(4-bromo-1,3-oxazepan-2-yl)-tetracyclo[4.
    4.
    0.
    12,5.
    17,10]hept-9-yl]-1,4-benzoxazepine using a reducing agent such as lithium aluminum hydride (LiAlH4) to form trifluoperidol.


    Overall, the production process of trifluoperidol involves several steps, including the synthesis of


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.